SCHEMBL6513952

SCHEMBL6513952

CCCC=C[C@@]1(n2cnc3c(N)ncnc32)O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 5/20 0.48
▸ ADORA2A P29274 3/20 0.48
▸ PI4KA P42356 2/20 0.46
▸ PI4K2B Q8TCG2 2/20 0.46
▸ PI4K2A Q9BTU6 2/20 0.46
▸ PI4KB Q9UBF8 2/20 0.46
▸ SLC28A1 O00337 2/20 0.45
▸ DPP4 P27487 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ MAP3K7 O43318 1/20 0.45
▸ SLC28A2 O43868 1/20 0.45
▸ GAPDH P04406 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ ADORA2B P29275 1/20 0.45
▸ ADORA1 P30542 1/20 0.45
▸ STAT6 P42226 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ DOT1L Q8TEK3 1/20 0.45
▸ SLC29A1 Q99808 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6513941 1.00 ADORA3 (0.48) ADORA3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL10776201 0.86 ADORA3 (0.49) ADORA3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL1934654 0.83 ADORA3 (0.53) ADORA3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL3831039 0.83 ADORA3 (0.53) ADORA3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL29401884 0.83 ADORA3 (0.53) ADORA3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL2534138 0.79 ADORA3 (0.52) ADORA3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL30716126 0.78 ADORA3 (0.54) ADORA3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL3698843 0.78 ADORA3 (0.54) ADORA3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL16258664 0.78 PI4KA (0.55) ADORA3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL13061814 0.78 PI4KA (0.55) ADORA3ADORA2API4KAPI4K2BPI4K2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110430894-A Immunomodulatory therapeutic MRNA compositions encoding peptides that activate oncogene mutations MODERNATX INC 2019-11-08 — — CN disclosed
CN-110402145-A For enhancing the messenger RNA and its application method of immune response MODERNATX INC 2019-11-01 — — CN disclosed
CN-108472354-A Respiratory syncytial virus vaccines 摩登纳特斯有限公司 2018-08-31 — — CN disclosed
CN-108472355-A HSV vaccine 摩登纳特斯有限公司 2018-08-31 — — CN disclosed
US-20050176043-A1 Methods of detecting human diseases using a human genomic polynucleotide BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2005-08-11 — — US disclosed
Send feedback